SG44701A1 - Adenosine derivatives - Google Patents

Adenosine derivatives

Info

Publication number
SG44701A1
SG44701A1 SG1996005914A SG1996005914A SG44701A1 SG 44701 A1 SG44701 A1 SG 44701A1 SG 1996005914 A SG1996005914 A SG 1996005914A SG 1996005914 A SG1996005914 A SG 1996005914A SG 44701 A1 SG44701 A1 SG 44701A1
Authority
SG
Singapore
Prior art keywords
adenosine derivatives
adenosine
derivatives
Prior art date
Application number
SG1996005914A
Other languages
English (en)
Inventor
Brian Evans
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SG44701A1 publication Critical patent/SG44701A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996005914A 1987-12-23 1988-12-22 Adenosine derivatives SG44701A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729994A GB8729994D0 (en) 1987-12-23 1987-12-23 Chemical compounds

Publications (1)

Publication Number Publication Date
SG44701A1 true SG44701A1 (en) 1997-12-19

Family

ID=10628947

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005914A SG44701A1 (en) 1987-12-23 1988-12-22 Adenosine derivatives

Country Status (36)

Country Link
US (1) US5032583A (fr)
EP (1) EP0322242B1 (fr)
JP (1) JP2736088B2 (fr)
KR (1) KR890009967A (fr)
CN (1) CN1024198C (fr)
AT (1) ATA315488A (fr)
AU (2) AU612747B2 (fr)
BE (1) BE1002167A5 (fr)
CA (1) CA1320195C (fr)
CH (1) CH677495A5 (fr)
CZ (1) CZ403991A3 (fr)
DE (2) DE3856154T2 (fr)
DK (1) DK170894B1 (fr)
ES (1) ES2012927A6 (fr)
FI (1) FI90429C (fr)
FR (1) FR2629715B1 (fr)
GB (2) GB8729994D0 (fr)
GR (1) GR1000307B (fr)
HK (1) HK1009650A1 (fr)
HU (1) HU203364B (fr)
IE (1) IE61302B1 (fr)
IL (1) IL88765A (fr)
IT (1) IT1224840B (fr)
LU (1) LU87414A1 (fr)
MX (1) MX14331A (fr)
NL (1) NL8803140A (fr)
NO (1) NO171506C (fr)
NZ (1) NZ227485A (fr)
PH (1) PH25932A (fr)
PL (1) PL158800B1 (fr)
PT (1) PT89328B (fr)
RU (2) RU1826971C (fr)
SE (1) SE8804609L (fr)
SG (1) SG44701A1 (fr)
YU (1) YU234188A (fr)
ZA (1) ZA889593B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
FR2665362B1 (fr) * 1990-08-03 1994-12-09 Cepbepe Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
ES2095960T3 (es) * 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
DK62692D0 (fr) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
BR9507683A (pt) * 1994-05-10 1997-09-23 Sandoz Ag Derivados de adenosina
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
WO1997033591A1 (fr) * 1996-03-13 1997-09-18 Novo Nordisk A/S Procede de traitement d'affections associees aux cytokines chez les mammiferes
WO1997033590A1 (fr) * 1996-03-13 1997-09-18 Novo Nordisk A/S Procede de traitement d'affections associees aux cytokines chez les mammiferes
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
BR9911612A (pt) 1998-06-02 2001-02-06 Osi Pharm Inc Composições de pirrolo[2,3d]pirimidina e seus usos
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6784165B1 (en) 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
GB0106867D0 (en) * 2001-03-20 2001-05-09 Glaxo Group Ltd Process
EP1258247A1 (fr) * 2001-05-14 2002-11-20 Aventis Pharma Deutschland GmbH Analogues d'adénosine pour le traitement de le diabete et de la resistance à l' insuline
JP2005529062A (ja) 2001-11-30 2005-09-29 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド アデノシンａ１及びａ３受容体に特異的な化合物とその使用
EP1465631B1 (fr) 2001-12-20 2010-02-24 OSI Pharmaceuticals, Inc. Composes pyrimidine antagonistes selectifs des recepteurs a2b, leur synthese et leur utilisation
CN101973998A (zh) 2001-12-20 2011-02-16 Osi药物公司 吡咯并嘧啶A2b选择性拮抗剂化合物
MXPA05011428A (es) * 2003-04-24 2006-05-31 Aderis Pharmaceuticals Inc Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
WO2005025545A2 (fr) * 2003-09-17 2005-03-24 Aderis Pharmaceuticals, Inc. Formulation a liberation controlee
AU2006320578B2 (en) * 2005-11-30 2013-01-31 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
BR112012004523A2 (pt) 2009-08-31 2015-09-08 Lonza Ag processo para a preparação de (1s,4r)-2-oxa-3-azabiciclo[2.2.1]hept-5-enos
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130136C (fr) * 1966-10-20
NL6717061A (fr) * 1966-12-21 1968-06-24
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
NL7203984A (fr) * 1971-04-10 1972-10-12
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
DE2148838A1 (de) * 1971-09-30 1973-04-05 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2157036A1 (de) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338705A1 (de) * 1973-07-31 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338963A1 (de) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2426682A1 (de) * 1974-06-01 1975-12-11 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
ZA857998B (en) * 1984-10-26 1986-05-28 Warner Lambert Co N6-substituted adenosines
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
HU203364B (en) 1991-07-29
AU2740188A (en) 1989-06-29
HUT48903A (en) 1989-07-28
IL88765A (en) 1993-04-04
CN1035295A (zh) 1989-09-06
GR1000307B (el) 1992-05-12
KR890009967A (ko) 1989-08-05
IE883845L (en) 1989-06-23
HK1009650A1 (en) 1999-06-04
EP0322242A3 (fr) 1990-04-18
CZ403991A3 (en) 1993-04-14
EP0322242B1 (fr) 1998-04-01
DE3856154D1 (de) 1998-05-07
IT1224840B (it) 1990-10-24
RU2060996C1 (ru) 1996-05-27
GB8829983D0 (en) 1989-02-15
GB8729994D0 (en) 1988-02-03
DK170894B1 (da) 1996-03-04
AU612747B2 (en) 1991-07-18
ATA315488A (de) 1994-02-15
MX14331A (es) 1993-12-01
NO171506C (no) 1993-03-24
AU8589491A (en) 1991-12-12
CA1320195C (fr) 1993-07-13
FI885943A (fi) 1989-06-24
CN1024198C (zh) 1994-04-13
NO885719D0 (no) 1988-12-22
US5032583A (en) 1991-07-16
DE3843609A1 (de) 1989-07-06
NO885719L (no) 1989-06-26
PT89328A (pt) 1989-12-29
DE3856154T2 (de) 1998-08-27
SE8804609D0 (sv) 1988-12-21
FI90429B (fi) 1993-10-29
IE61302B1 (en) 1994-10-19
JPH01203400A (ja) 1989-08-16
RU1826971C (ru) 1993-07-07
IL88765A0 (en) 1989-07-31
FR2629715A1 (fr) 1989-10-13
FI90429C (fi) 1994-02-10
GB2212498B (en) 1991-07-24
NO171506B (no) 1992-12-14
CH677495A5 (fr) 1991-05-31
DK713488D0 (da) 1988-12-21
IT8848714A0 (it) 1988-12-23
DK713488A (da) 1989-06-24
NZ227485A (en) 1991-06-25
JP2736088B2 (ja) 1998-04-02
BE1002167A5 (fr) 1990-08-28
NL8803140A (nl) 1989-07-17
ES2012927A6 (es) 1990-04-16
SE8804609L (sv) 1989-06-24
PL158800B1 (en) 1992-10-30
PT89328B (pt) 1993-08-31
ZA889593B (en) 1989-09-27
FR2629715B1 (fr) 1993-09-03
GB2212498A (en) 1989-07-26
YU234188A (en) 1990-12-31
PH25932A (en) 1991-12-19
EP0322242A2 (fr) 1989-06-28
LU87414A1 (fr) 1989-07-07
PL276697A1 (en) 1990-02-19

Similar Documents

Publication Publication Date Title
GB2212498B (en) Adenosine derivatives
GR3002864T3 (en) Azolylmethylcyclopropyl derivatives
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
GB8815258D0 (en) Thiorea derivatives
PH25577A (en) Purine derivatives
EP0305322A3 (en) Isoxazole-beta-carboline derivatives
EP0297383A3 (en) Hydroxyethyl-azolyl derivatives
GB2205829B (en) 2-aryl-4-isoxazolin-3-one derivatives
GB8705601D0 (en) Oxo-isoindolinyl derivatives
EP0322164A3 (en) Ethanolamie derivatives
GB8726272D0 (en) 4-demethoxy anthra-cycline derivatives
GB2200910B (en) Thiopilocarpine derivatives
GB8704236D0 (en) Anthracycline-oestrone derivatives
GB8725466D0 (en) Purine derivatives
GB8700016D0 (en) Quinolizinone derivatives
GB8715925D0 (en) Thiapentanamide derivatives
IE870359L (en) Purine derivatives
GB2211840B (en) Indenofuran derivatives
IE870520L (en) Isohexide nucleoside
IE871681L (en) Cytorhodin s derivatives
FI103571B1 (fi) Propoksibentseenijohdannaisia
IE870156L (en) Imidazo-quinoline derivatives
IE871081L (en) Thiadiazinone - tricyclic derivatives
IE871047L (en) Alkenamide derivatives
IE873382L (en) Pyridazodiazepine derivatives